This guide summarizes our core findings on GHK-Cu peptide research, before-and-after timelines, dosage considerations, and real-world user experiences
The July 23-24 PCAC meeting was convened to evaluate whether they should be added to the 503A Bulk Drug Substances List, which would give compounding pharmacies a clear legal framework to work with them
Adverse event data in humans is sparse
It says it will remove products from the market if they claim to treat or change how the body works if they are not licensed under the Human Medicines Regulations Act 2012, and that it strongly advises against purchasing and using unauthorised medicinal products - "particularly those promoted on social media".
Each dose of GHK-Cu contains a very small amount of copper relative to dietary intake
However: It can cause water retention, increased appetite, and insulin sensitivity changes in some users